Navigation Links
Alkermes Announces Positive Results from Phase 1/2 Clinical Study,of ALKS 29

ndpoints included the percent of days abstinent, percent of heavy drinking days, and number of drinks per day. Heavy drinking is defined as five or more drinks per day for men and four or more drinks per day for women.

About Alcohol Dependence

Alcohol dependence is a serious and chronic disease that affects multiple regions of the brain, providing rationale for the use of medication with psychosocial support as part of an integrated treatment plan. Underlying neurological and genetic factors, as well as environmental factors, play a role in alcohol dependence;(1) therefore, there is a need for a variety of treatment options that can be tailored to best suit patients' needs. Psychosocial support, such as counseling or group therapy, is the traditional approach for treating alcohol dependence; however, experts in the field increasingly recommend and support a treatment approach that includes a combination of medication and psychosocial support.(2,3)

Of the more than 18 million Americans who abuse or are dependent on alcohol,(4) approximately 2.2 million seek treatment for their alcohol problems.(5) Alcohol abuse and dependency are an economic burden to society that cost approximately $185 billion annually in the U.S.(6)

About Alkermes

Alkermes, Inc. is a biotechnology company that develops innovative medicines designed to yield better therapeutic outcomes and improve the lives of patients with serious disease. Alkermes currently has two commercial products: RISPERDAL(R) CONSTA(R) ((risperidone) long-acting injection), the first and only long-acting atypical antipsychotic medication approved for use in schizophrenia, and marketed worldwide by Janssen-Cilag (Janssen), a wholly owned division of Johnson & Johnson; and VIVITROL(R) (naltrexone for extended-release injectable suspension) the first and only once-monthly injectable medication approved for the treatment of alcohol dependence and marketed in the U.S. primarily by Cephalon,
'"/>




Page: 1 2 3 4

Related medicine technology :

1. Antisoma Announces Further Data From ASA404 Ovarian Cancer Trial
2. Neose Announces Presentation of Positive Preclinical Data on GlycoPEGylated Factor VIIa at the XXI Congress of the International Society on Thrombosis and Haemostasis
3. Biofrontera AG Announces Clinical Study Confirms Excellent Efficacy of BF-200 ALA In Actinic Keratosis
4. YM BioSciences Announces Secondary Efficacy and Safety Findings in Randomized Phase IIB Aerolef Trial
5. BioSante Pharmaceuticals Announces New Findings for Potential Bird Flu Vaccine
6. Portola Pharmaceuticals Announces Positive Data from a Phase II Study of its Factor Xa Inhibitor at the XXI Congress of the International Society on Thrombosis and Haemostasis
7. Manhattan Pharmaceuticals Announces Results of Phase 2a Studies for Oral Oleoyl-estrone
8. AVI BioPharma Partner Cook Medical Announces Completion of Patient Enrollment for APPRAISAL Phase II Clinical Trial for Treatment of Cardiovascular Disease
9. Protox Announces Positive Clinical Data from Prostate Cancer Study
10. Inspire Announces Webcast of Presentation at C.E. Unterberg, Towbin Emerging Growth Opportunities Conference
11. NexMed Announces Completion of Patient Enrollment in Two Pivotal Phase 3 Studies for Anti-Fungal Product
Post Your Comments:
(Date:7/3/2015)... A global continuing medical education provider is ... in Central and South-East Asia ... dedicated to these diseases.      (Logo: http://photos.prnewswire.com/prnh/20150630/227090) ... Manage Hypertension Online and Manage Thyroid Online ... - combine the world,s top expertise with dynamic ...
(Date:7/3/2015)... A global continuing medical education ... thyroid disorders in Latin America ... dedicated to these diseases.      (Logo: http://photos.prnewswire.com/prnh/20150630/227033) ... Manage Hypertension Online and Manage Thyroid Online ... - combine the world,s top expertise with dynamic ...
(Date:7/3/2015)... , July 3, 2015 Redwood ... Broda Technologies Co., Ltd., operating in both the US ... company,s proprietary IntelliGel ® supramolecular hydrogel technology in ... and other ophthalmic therapies. The Broda technology offers many ... is a free-forming liquid and with low concentrations of ...
Breaking Medicine Technology:Combating Three Major Chronic Diseases in Central and South-East Asia With Medical Education 2Combating Three Major Chronic Diseases in Latin America With Medical Education 2Redwood Pharma Licenses Novel Hydrogel Drug Delivery Technology From Broda Technologies 2
... 28 BioCis Pharma Ltd., a,privately-held drug development ... Phase I clinical testing of ProtoCure(TM) intravesical,instillation solution, ... is based on a new mechanism of action ... cancer growth and proliferation,locally. , ...
... a leader in the field of human gene therapy,announced ... Drug,Designation to AMT,s gene therapy product AMT-021 for the ... Orphan Drug Designation for AIP entitles AMT to ... AMT-021 if this,product candidate is the first new drug ...
Cached Medicine Technology:BioCis Pharma Starts a Phase I Clinical Trial With a New Cancer Drug 2AMT Receives EMEA Orphan Drug Designation for Acute Intermittent Porphyria 2AMT Receives EMEA Orphan Drug Designation for Acute Intermittent Porphyria 3
(Date:7/6/2015)... Newport News, VA (PRWEB) , ... July 06, ... ... announced today that Dr. Jeffrey R. Carlson finished his 100th case using SpineFrontier’s® ... Bon Secours Mary Immaculate Hospital in Newport News, VA. The procedure was an ...
(Date:7/5/2015)... , ... July 06, 2015 , ... ... benefits market, is excited to announce the next generation of PrimeStar Individual Dental ... plans to now include two network options—Maximum Allowable Charge (MAC) and usual, customary ...
(Date:7/5/2015)... , ... July 05, 2015 , ... Women’s Excellence ... college) at their Lake Orion location. The special consists of 2 months of unlimited ... Wellness, powered by Movestrong is located at 1410 South Lapeer Road in Lake Orion. ...
(Date:7/4/2015)... ... July 04, 2015 , ... Chronic Neck Pain. Neck ... sufferers have pain located in the neck. Another 19% suffer from head, migraine, or ... literature suggests that 45% of American workers must deal with neck pain. ...
(Date:7/3/2015)... ... 03, 2015 , ... Brendon Burchard's new High Performance ... media attention. In an effort to spread the news, a comprehensive review of ... many people are feeling overwhelmed by stress and fatigue," reports Hendricks. "Many folks ...
Breaking Medicine News(10 mins):Health News:100th Outpatient Less Exposure Surgery Procedure Completed by Industry Leading Surgeon Dr. Jeffrey Carlson 2Health News:100th Outpatient Less Exposure Surgery Procedure Completed by Industry Leading Surgeon Dr. Jeffrey Carlson 3Health News:Security Life Insurance Company of America Launches the Next Generation of PrimeStar Individual Dental Insurance Plans 2Health News:New Advancement in Treatment of Chronic Neck Pain 2Health News:New Advancement in Treatment of Chronic Neck Pain 3Health News:High Performance Academy - Review Of Brendon Burchard's New High Performance Training Program Released 2Health News:High Performance Academy - Review Of Brendon Burchard's New High Performance Training Program Released 3
... is said to be vulnerable to a specific health ... colleagues from Institute for Clinical Evaluative Sciences in Toronto. ... more prone to pelvic fractures and Pisceans should be ... women born under the sign of Virgo vomit more ...
... to the survey conducted by India's National Family Health Survey, ... covers around 200,000 people and is the third one since ... indicates that infant mortality in rural areas is 62% while ... are 46% while in China it is only 8%. On ...
... has announced Nigeria's donation of $10 million to the ... HIV/AIDS, malaria and// tuberculosis. ,The President made ... of the Board of Friends of the Global Fund ... holding in Kigali, Rwanda, on Monday February 12. ...
... of the oral cavity even in low doses.// ... to counteract the production of acid between the teeth. ... reduction of the sugar xylose, or wood sugar. Xylitol occurs ... It is used in sugarless sweets, especially in chewing gum ...
... Indian doctors have so far returned home after failing to ... forced them to live with rats, cockroaches and scrounge for ... of 5,000 returning to India is since April 2006 when ... by the Indian medical community in court but a judicial ...
... bedtime, could make you sleep quicker,// says a new study. ... of Sydney studied 12 healthy men who were 18-35 years ... rice in their meals - plain rice, long-grain rice and ... rice has a high glycemic index - a ranking system ...
Cached Medicine News:Health News:Health Disorders Linked To Astrological Signs 2Health News:Xylitol Fights Oral Bacteria 2Health News:Indian Doctors Return Home from Britain, More on the Way 2Health News:Indian Doctors Return Home from Britain, More on the Way 3
... Growth Factor Binding Protein-1 (IGFBP-1) is a ... specifically binds and modulates the bioactivity of ... IGFBP-1 has not been completely defined, but ... IGFBP-1 may be involved in glucose regulation ...
... gland and gonads, is the immediate precursor ... which may be subsequently converted to estradiol. ... at ~(less than or equal to) 20% ... often exceed testosterone in both normal and ...
... Insulin-like growth factor II (IGF-II) is a ... the liver and is postulated to have mitogenic ... actions of IGF-II are mediated by binding to ... to the Type II IGF receptor, a monomeric ...
... weight of 16 kDa. Leptin is a protein ... [1,2]. Leptin is thought to play a key ... In the human, leptin levels are elevated with increasing ... relationship between serum leptin levels and several measures of ...
Medicine Products: